Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Phillip Suwalski has a total of 212 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cytokine-associated ROS and Ca2+ dysregulation in severe inflammatory cardiomyopathy

    by Phillip Suwalski, Ainoosh Golpour, January Weiner, Nicolas Musigk, Felix Balzer, Niklas Giesa, Ali Amr, Joanna Zyla, Peter Ganz, Hafiza Nosheen Saleem, et al.

    Aims: Inflammatory cardiomyopathy (iCMP) is a leading cause of heart failure, with limited therapeutic options. Excessive cytokine levels are implicated in adverse outcomes, but their pathomechanism in iCMP is poorly understood. We sought to identify key cytokines involved in severe iCMP and elucidate their potential contribution to cardiomyocyte injury. Methods and results: Cytokines were analysed in patients with severe biopsy-proven iCMP (n = 63; LVEF ≤ 35%) and validated in a national cohort (n = 425). In vitro experiments examined the effect of the top cytokines observed in severe iCMP with regards to production of reactive oxygen species (ROS) and calcium homeostasis in induced human pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) and human aortic endothelial cells (HAECs). Three proteins (COLEC-12, CRIM-1, IL-6) were associated with severe iCMP. In iPSC-CMs, these proteins increased ROS (H2DCFDA assay) and intracellular Ca2+ levels (Fluo-4AM assay), indicating cellular stress. Effects were less pronounced in HAEC. Finally, real-world data from electronic medical records suggested a possible cardioprotective effect of clinically available inhibitors targeting these cytokines, although these findings remain exploratory and require confirmation in controlled studies. Conclusion: COLEC-12, CRIM-1, and IL-6 are elevated in severe iCMP and induce oxidative stress and calcium dysregulation in cultured cardiomyocytes. These findings highlight their potential as possible future therapeutic targets. Clinical Trial number: ClinicalTrials.gov Identifier: NCT04265040, NCT02187263

  • Open Access

    The MagMa Study

    by Phillip Suwalski, Finn Wilke, Ekaterina Latinova, Gabriele Paci, Gamze Satilmis, Karin Klingel, Sebastian Kelle, January Weiner, Dieter Beule, Thomas F. Lüscher, et al.

  • Open Access

    Evaluation of Cytokine Levels in Cardiac Transthyretin and Immunoglobulin Light Chain Amyloidosis and Their Correlation with Myocardial Inflammatory Cells and MACE

    by Nicolas Musigk, Phillip Suwalski, Maximilian Müller, Michele Violano, Karin Klingel, January Weiner, Dieter Beule, Ulf Landmesser, Bettina Heidecker

    Aims: Myocardial inflammation in cardiac amyloidosis is associated with poor clinical outcomes. This study aimed to (a) investigate the relationship between peripheral blood cytokine levels and the presence of inflammatory cells within the myocardium, and to (b) evaluate the potential of cytokines as predictors of major adverse cardiovascular events (MACE) in transthyretin (ATTR) and immunoglobulin light chain (AL) cardiac amyloidosis. Methods: Peripheral blood samples were collected from 50 patients with cardiac ATTR or AL amyloidosis between 2018 and 2023 at baseline and every three months during follow-up visits. Cytokine analysis was performed using Olink’s Proximity Extension Assay. For MACE prediction analysis, only patients with MACE occurring within ±14 days of a study visit were included (n = 16). Associations were evaluated using linear models. Results: No significant associations were identified between the EMB-confirmed myocardial presence of inflammatory cells and cytokine levels. There was a trend of weak-to-moderate associations between serial blood cytokine levels and MACE, albeit this was non-significant after adjustment for multiple testing (FDR): r2 = 0.28 for PON3 (p = 0.00075, FDR = 0.28), SIGLEC1 (p = 0.00077, FDR = 0.28), and IL-6 (p = 0.00086, FDR = 0.31). Conclusions: Peripheral blood cytokine levels were not reliable biomarkers for the myocardial presence of inflammatory cells. PON3, SIGLEC1, and IL-6 demonstrated a statistically non-significant trend of a weak-to-moderate association with MACE in cardiac amyloidosis. Since we recently demonstrated that amyloidosis with an inflammatory component is associated with poor outcomes, these additional findings underscore the need for alternative approaches to identify and manage inflammation in this patient population.

  • Top Cited Papers

    Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score

    by Giovanni Peretto, Marco Merlo, Alessandro Ambrosi, Elena Bacigalupi, Andrea Villatore, Lucia Molinari, Ignasi Anguera, Eduard Claver, Matteo Dal Ferro, Phillip Suwalski, et al.

    Background and Aims: The prediction of the first major arrhythmic event (MAE) is still an unmet need in the recently defined scenario of non-dilated left ventricular cardiomyopathy (NDLVC). Methods: A cohort of 337 patients with NDLVC and no history of MAE was retrospectively identified at two large centres. Patient-tailored diagnostic workup included cardiac magnetic resonance (CMR), endomyocardial biopsy, and genetic testing. The primary endpoint was the occurrence of the first MAE, including sustained ventricular tachycardia (VT), ventricular fibrillation, or appropriate implantable cardioverter-defibrillator therapy, by 60-month follow-up. A pool of 216 NDLVC patients from 11 European centres served as a validation cohort. Results: In the study cohort (mean age 37 ± 15 years, 62% male), the mean left ventricular ejection fraction (LVEF) was 52 ± 8%, and 79% of patients had late gadolinium enhancement (LGE) at baseline CMR. By 60-month follow-up, 51 patients (15%) experienced a MAE. The primary endpoint was predicted by male sex [hazard ratio (HR) 2.4, 95% confidence interval (CI) 1.3–4.4, P = .007], baseline non-sustained VT (HR 3.1, 95% CI 1.7–5.6, P < .001), LVEF < 45% (HR 5.5, 95% CI 2.7–11.0, P < .001), septal (HR 2.0, 95% CI 1.0–4.0, P = .046) and ring-like pattern of LGE (HR 1.3, 95% CI .6–2.6, P = .54), pathogenic/likely pathogenic variants in guideline-defined high-risk genes (HR 4.6, 95% CI 2.3–9.1, P < .001), and biopsy/CMR-proven myocardial inflammation (HR 15.7, 95% CI 6.1–40.3, P < .001). The results were confirmed in the validation cohort (Uno’s C-index 0.81, 95% CI .75–.88). A novel risk score was subsequently derived. Conclusions: In NDLVC, male sex, non-sustained VT, LVEF < 45%, septal and ring-like LGE, high-risk genotypes, and myocardial inflammation predicted the first episode of MAE by 60 months.


  • Open Access

    The MagMa Study: Quantum Magnetocardiography in Non-Ischemic Cardiomyopathy

    by Phillip Suwalski, Finn Wilke, Ekaterina Latinova, Gabriele Paci, Gamze Satilmis, Karin Klingel, Sebastian Kelle, January Weiner, Dieter Beule, Thomas F. Lüscher, et al.

    Background Rapid diagnostic screening is an unmet need in patients with suspected cardiomyopathy. We recently demonstrated that magnetocardiography (MCG) might be a suitable tool to detect cardiomyopathies. We now tested diagnostic accuracy of MCG prospectively. Methods MCG uses a superconducting quantum interference device (SQUID) to detect the electromagnetic field of the heart. In our recent retrospective study, a T-beg-Tmax (MCG Score) > 0.051 identified patients with non-ischemic cardiomyopathy. We assessed the diagnostic accuracy of MCG compared to advanced imaging and/or endomyocardial biopsy (EMB). Results from EMB took precedence over advanced imaging. We enrolled 110 patients with angina-like symptoms after exclusion of coronary artery disease (Power calculation: Expected 80% power at a 5% significance level) from the emergency department, in-patient wards and outpatient clinics. Exclusion criteria included presence of intracardiac metal devices and treatment with immunosuppressants. We incorporated 220 healthy individuals using 1:2 propensity score matching (age, sex) for a total of 330 participants. Results MCG detected cardiomyopathy with 94.74% sensitivity (95% CI: 85-99%), 98.54% specificity (95% CI: 96-100%), 93.1% negative predictive value (NPV, 95% CI: 84-98%) and 94.34% positive predictive value (PPV, 95% CI: 84-98%). In 3 patients, CMR failed to detect non-ischemic cardiomyopathy, whereas MCG showed pathological results consistent with results of EMB. Results were highly reproducible (statistical uncertainty: 2.5%, T-beg-Tmax (MCG Score) +/− 0.004). Conclusion MCG offers a non-invasive, reproducible methodology for rapid and accurate detection of non-ischemic cardiomyopathy. Our data indicate that MCG may be an efficient tool for allocation of advanced imaging to those in greatest need.


  • Open Access Data and Deep Learning for Cardiac Device Identification on Standard DICOM and Smartphone-based Chest Radiographs

    by Felix Busch, Keno K. Bressem, Phillip Suwalski, Lena Hoffmann, Stefan M. Niehues, Denis Poddubnyy, Marcus R. Makowski, Hugo J. W. L. Aerts, Andrei Zhukov, Lisa C. Adams

    "Just Accepted" papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. Purpose To develop and evaluate a publicly available deep learning model for segmenting and classifying cardiac implantable electronic devices (CIEDs) on Digital Imaging and Communications in Medicine (DICOM) and smartphone-based chest radiograph (CXR) images. Materials and Methods This institutional review board-approved retrospective study included patients with implantable pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, and cardiac monitors who underwent chest radiography between January 2012 and January 2022. A U-Net model with a ResNet-50 backbone was created to classify CIEDs on DICOM and smartphone images. Using 2,321 CXRs from 897 patients (median age, 76 years (range 18-96 years); 625 male, 272 female), CIEDs were categorized into four manufacturers, 27 models, and one 'other' category. Five smartphones were used to acquire 11,072 images. Performance was reported using the Dice coefficient on the validation set for segmentation or balanced accuracy on the test set for manufacturer and model classification, respectively. Results The segmentation tool achieved a mean Dice coefficient of 0.936 (IQR: 0.890-0.958). The model had an accuracy of 94.36% (95% CI: 90.93%-96.84%; n = 251/266) for CIED manufacturer classification and 84.21% (95% CI: 79.31%-88.30%; n = 224/266) for CIED model classification. Conclusion The proposed deep learning model, trained on both traditional DICOM and smartphone images, showed high accuracy for segmentation and classification of CIEDs on CXRs. ©RSNA, 2024.


  • Abdominal Aortic Calcification is Associated with Degeneration of The Paraspinal Muscles – A Retrospective cross-sectional Study

    by Friederike Schömig, Lukas Schönnagel, Jiaqi Zhu, Phillip Suwalski, Paul Köhli, Thomas Caffard, Ali E. Guven, Erika Chiapparelli, Artine Arzani, Krizia Amoroso, et al.

    Study Design.: Retrospective cohort study. Objective.: To analyze the relationship of abdominal aortic calcification (AAC) and a reduction in the cross-sectional area (CSA) and the fatty infiltration (FI) of the paravertebral muscles in patients undergoing lumbar fusion surgery. Background.: Both AAC and paraspinal muscle degeneration have been shown to be associated with poorer outcomes after surgical treatment of degenerative diseases of the lumbar spine. However, there is a lack of data on the association between AAC and paraspinal muscle changes in patients undergoing spine surgery. Methods.: We retrospectively analyzed patients undergoing lumbar fusion for degenerative spinal pathologies. Muscular and spinal degeneration were measured on magnetic resonance imaging (MRI). AAC was classified on lateral lumbar radiographs. The association of AAC and paraspinal muscle composition was assessed by a multivariate regression analysis adjusted for age, sex, body mass index (BMI), comorbidities, and lumbar degeneration. Results.: A total of 301 patients was included. Patients with AAC showed significantly higher degrees of intervertebral disc and facet joint degeneration as well as higher total endplate scores at the L3/4 level. The univariable regression analysis showed a significant positive correlation between the degree of AAC and the FI of the erector spinae (b=0.530, PPP=0.006) and a significant negative correlation between the degree of AAC and the CSA of the psoas muscle (b=-0.260, P=0.003). Conclusion.: This study demonstrates a significant and independent association between AAC and degeneration of the erector spinae and the psoas muscles in patients undergoing lumbar fusion. As both AAC and degeneration of paraspinal muscles impact postoperative outcomes negatively, preoperative assessment of AAC may aid in identifying patients at higher risk after lumbar surgery.


  • Open Access

    The inflammatory spectrum of cardiomyopathies

    by Nicolas Musigk, Phillip Suwalski, Ainoosh Golpour, DeLisa Fairweather, Karin Klingel, Pilar Martin, Andrea Frustaci, Leslie T. Cooper, Thomas F. Lüscher, Ulf Landmesser, et al.

    Infiltration of the myocardium with various cell types, cytokines and chemokines plays a crucial role in the pathogenesis of cardiomyopathies including inflammatory cardiomyopathies and myocarditis. A more comprehensive understanding of the precise immune mechanisms involved in acute and chronic myocarditis is essential to develop novel therapeutic approaches. This review offers a comprehensive overview of the current knowledge of the immune landscape in cardiomyopathies based on etiology. It identifies gaps in our knowledge about cardiac inflammation and emphasizes the need for new translational approaches to improve our understanding thus enabling development of novel early detection methods and more effective treatments.


  • Open Access

    A burning heart: combined therapy of checkpoint-inhibitors and prednisolone in a patient with sarcoidosis

    by Finn Wilke, Edward J. Miller, Javid Moslehi, Phillip Suwalski, Ulf Landmesser, Bettina Heidecker

    Patients with prior autoimmune diseases such as sarcoidosis require special care when treated with checkpoint inhibitors (CPIs), given the risk for reactivation of inflammation. Here, we address the clinical dilemma of initiating CPIs for recurrent metastatic carcinoma in a patient with extensive sarcoidosis, controlled after prolonged immunosuppressive therapy when the tumor recurrence was detected. To achieve the best possible outcome, the case was discussed by an interdisciplinary team comprising specialists in rheumatology, oncology, and CPI-related myocarditis. Literature on this topic was very limited. Based on the pharmacodynamics of CPIs and the pathophysiology of CPI-related autoimmune diseases, we concluded that initiating CPIs alongside low-dose prednisolone would effectively suppress any reactivation of sarcoidosis without interfering with CPIs in a relevant way.